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Abstract
Background: Gingivitis has been linked to adverse pregnancy outcome (APO). Bacterial vaginosis (BV)
has been associated with APO. We assessed if bacterial counts in BV is associated with gingivitis suggesting
a systemic infectious susceptibilty.
Methods: Vaginal samples were collected from 180 women (mean age 29.4 years, SD ± 6.8, range: 18 to
46), and at least six months after delivery, and assessed by semi-quantitative DNA-DNA checkerboard
hybridization assay (74 bacterial species). BV was defined by Gram stain (Nugent criteria). Gingivitis was
defined as bleeding on probing at ≥ 20% of tooth sites.
Results: A Nugent score of 0–3 (normal vaginal microflora) was found in 83 women (46.1%), and a score
of > 7 (BV) in 49 women (27.2%). Gingivitis was diagnosed in 114 women (63.3%). Women with a diagnosis
of BV were more likely to have gingivitis (p = 0.01). Independent of gingival conditions, vaginal bacterial
counts were higher (p < 0.001) for 38/74 species in BV+ in comparison to BV- women. Counts of four
lactobacilli species were higher in BV- women (p < 0.001). Independent of BV diagnosis, women with
gingivitis had higher counts of Prevotella bivia (p < 0.001), and Prevotella disiens (p < 0.001). P. bivia, P. disiens,
M. curtisii and M. mulieris (all at the p < 0.01 level) were found at higher levels in the BV+/G+ group than
in the BV+/G- group. The sum of bacterial load (74 species) was higher in the BV+/G+ group than in the
BV+/G- group (p < 0.05). The highest odds ratio for the presence of bacteria in vaginal samples (> 1.0 ×
104 cells) and a diagnosis of gingivitis was 3.9 for P. bivia (95% CI 1.5–5.7, p < 0.001) and 3.6 for P. disiens
(95%CI: 1.8–7.5, p < 0.001), and a diagnosis of BV for P. bivia (odds ratio: 5.3, 95%CI: 2.6 to 10.4, p < 0.001)
and P. disiens (odds ratio: 4.4, 95% CI: 2.2 to 8.8, p < 0.001).
Conclusion: Higher vaginal bacterial counts can be found in women with BV and gingivitis in comparison
to women with BV but not gingivitis. P. bivia and P. disiens may be of specific significance in a relationship
between vaginal and gingival infections.
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Adverse preterm outcomes occur in approximately 10% of
all pregnancies [1]. It remains a major source of neonatal
morbidity and mortality. The prevalence of periodontitis
in women of childbearing age is unknown. Gingivitis is a
reversible inflammatory condition of keratinized and
non-keratinized gum tissues surrounding the teeth. Perio-
dontitis is a non-reversible inflammatory condition that
also includes loss of alveolar bone and other tooth sup-
porting structures. Infection with a diverse microflora is
the etiology of both these conditions. The association
between gingivitis or periodontitis and an increased risk
of preterm birth remains a matter of dispute. Several
recent studies support the hypothesis that periodontal
infectious disease is a risk factor for adverse pregnancy
outcomes [2-8]. One hypothesized mechanism is that
inflammation may upregulate the inflammatory response
in anatomically distinct locations such as the uterus and
the amniotic cavity [7-9].
Bacterial vaginosis (BV), a condition characterized by
decreased vaginal lactobacilli and increased anaerobic
bacteria, has been associated with an increased risk of pre-
term birth [10,11]. The abnormal microflora typical of BV
overlaps considerably with bacterial species known to be
associated with periodontal disease. For example, Prevo-
tella bivia and Porphyromonas sp. have been associated with
BV [12], whereas Prevotella intermedia and Porphyromonas
gingivalis have been associated with periodontal disease
[13,14]. Higher counts of colony forming units of P. gin-
givalis in subgingival samples have also been observed in
women who subsequently delivered prematurely [8,15].
Despite such findings, the biological relationship between
oral and vaginal infections has not been extensively stud-
ied.
The purpose of the present study was to characterize the
bacterial species in vaginal samples from women of child-
bearing age in relation to clinical evidence of gingival
inflammation (gingivitis) and bacterial vaginosis. We
hypothesized that the vaginal microflora differed between
women with or without overt clinical evidence of gingivi-
tis. We also hypothesized a co-occurrence of BV and gin-
givitis.
Methods
The Human Research Review Board of the Washington
State Department of Health approved the study. All sub-
jects signed informed written consent as required by the
IRB. The study cohort included parous women with no
known systemic disease, who were recruited based on a
previous history of early preterm delivery (20–34 weeks
gestation) or term delivery (≥ 37 weeks gestation). A pre-
term birth occurred among 17 (9.2%) of the women par-
ticipating in the present study. All women had delivered
at least 6 months prior to study entry and microbiological
sampling.
The women had a gynecological examination with collec-
tion of vaginal by insertion of a Dacron swab into the vag-
inal vault. One swab was used to prepare an air-dried slide
for Gram stain for BV diagnosis according to the Nugent
criteria [11]. A second swab tip was placed in a cryovial
eluted in 0.9 ml phosphate buffered saline and stored at -
80°C until transported on dry ice by express courier to the
Oral Microbiology Laboratory at the University of Berne,
Switzerland, for analysis of microbial content.
Women also had a standard periodontal examination at
the Regional Clinical Dental Research Center (RCDRC),
School of Dentistry at the University of Washington, Seat-
tle, WA. Gingivitis was defined as having ≥ 20% of gingi-
val sites surfaces (six examined per tooth) with bleeding
on probing (BOP). This cutoff level is considered a useful
criterion to establish gingivitis and is used as a basic prin-
ciple in the standard practice of periodontal care. Clinical
probing pocket depths around all teeth and intra-oral
radiographs were also assessed to define if the women
also had a diagnosis of periodontitis (alveolar bone loss
and evidence of increased probing pocket depth/clinical
attachment loss).
A total of 180 women who had given birth at least six
months prior to enrollment were included in this analysis.
Their mean age was 29.4 years (SD ± 6.8, range: 18 to 46).
The racial groups were as follows: 60 Caucasians (32.6%),
82 African-Americans (44.6%), 9 Native Americans
(4.9%), and 33 of other races (17.9%).
Microbiological processing
At the microbiology laboratory, 300 μl Tris EDTA buffer
(10 mM Tris-HCL, 1.0 mM EDTA, pH 7.6) was added to
each vial with a vaginal swab, allowed to stand for 10 min-
utes, and was then sonicated for 10 seconds. Subse-
quently, 200 μl of freshly made 0.5 M NaOH was added
to each vial and the swab was removed before freezing the
sample. Samples were then processed within three
months. Before processing, the samples were diluted four-
fold with Tris EDTA buffer and aliquoted into two vials.
These were processed by the checkerboard DNA-DNA
hybridization method as described in detail elsewhere
[16-19]. DNA probes used in the checkerboard DNA-DNA
format provide a useful tool for the enumeration of bacte-
rial species in microbiologically complex systems [17].
One vial was used to check for the presence of the species
of which probes were present on the first panel, the other
vial for the species of the second panel (Table 1). The
information was digitized and analyzed by the software
program ImageQuant (Amersham Pharmacia, Piscata-
way, NJ) allowing comparison of signal intensities againstPage 2 of 8
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106 bacterial cells in the appropriate checkerboard slot for
all species. Routine laboratory assessment of the repro-
ducibility suggested a very high level of reliability varying
within species by 1–2%. Signals were converted to semi-
quantitative counts by comparison with these standards.
For dichotomous analysis of the data, a signal strength of
≥ 1 × 104 bacterial cells was considered as positive. The
species that were studied are listed in Table 1. The species
listed in Panel 1 are commonly assessed by the checker-
board DNA-DNA hybridization method in studies of bac-
teria associated with periodontitis [19,20]. These were
either part of the original microbiological laboratory
library of species [19,20] or had been provided by the
Department of Clinical Chemistry, Microbiology and
Immunology at the University of Ghent, Belgium
(UGent). Some species or DNA had been purchased from
LGC Promochem, Molsheim, France. The identification of
species from the University of Ghent has been described
elsewhere [21-24]. Thus the bacteria listed in Panel 2 are
commonly assessed in studies of BV.
Statistical methods
We used One-way ANOVA (Bonferonni post-hoc test)
and non-parametric Mann-Whitney U tests, and Kruskal-
Wallis ANOVA to assess differences in the quantity of each
Table 1: Bacterial species and subspecies included in the DNA-DNA checkerboard assay
Species Panel 1 Collection* Species Panel 2 Collection*
1a. Aggregatibacter actinomycetemcomitans (a) ATCC 29523 1. Actinomyces neuii GUH 550898
1b. Aggregatibacter actinomycetemcomitans (Y4) ATCC 43718 2. Aerococcus christensenii GUH 070938
2. Actinomyces israelii ATCC 12102 3. Anaerococcus vaginalis GUH 290486
3. Actinomyces naeslundii (type I + II) ATCC 43146 4. Atopobium parvulum GUH 160323
4. Actinomyces odontolyticum ATCC 17929 5. Atopobium vaginae GUH 010535
5. Campylobacter gracilis ATCC 33236 6. Bacteroides ureolyticus GUH 080189
6. Campylobacter rectus ATCC 33238 7. Bifidobacterium biavatii GUH 071026
7. Campylobacter showae ATCC 51146 8. Bifidobacterium bifidum GUH 070962
8. Capnocytophaga gingivalis ATCC 33612 9. Bifidobacterium breve GUH 080484
9. Capnocytophaga ochraceae ATCC 33596 10. Bifidobacterium longum GUH 180689
10. Capnocytophaga sputigena ATCC 33612 11. Corynebacterium aurimucosum GUH 450453
11. Eikenella corrodens ATCC 23834 12. Corynebacterium nigricans GUH 071035
12. Eubacterium saburreum ATCC 33271 13. Dialister sp. GUH071045
13a. Fusobacterium nucleatum subsp. Nucleatum ATCC 25586 14a. Enterococcus faecalis GUH170812
13b. Fusobacterium nucleatum subsp. Polymorphum ATCC 10953 14b. Enterococcus faecalis ATCC 29212
13c. Fusobacterium nucleatum subsp.Naviforme ATCC 49256 15. Escherichia coli GUH 070903
14. Fusobacterium periodonticum ATCC 33693 16. Gardnerella vaginalis GUH 080585
15. Lactobacillus acidophilus ATCC 11975 17. Haemophilus influenzae ATCC 49247
16. Leptotrichia buccalis ATCC 14201 18. Helicobacter pylori ATCC 43504
17. Parvimonas micra ATCC 19696 19. Lactobacillus crispatus GUH 160342
18. Neisseria mucosa ATCC 33270 20. Lactobacillus gasseri GUH 170856
19. Prevotella intermedia ATCC 25611 21. Lactobacillus iners GUH 160334
20. Prevotella melaninogenica ATCC 25845 22. Lactobacillus jensenii GUH 160339
21. Prevotella nigrescens ATCC 33563 23. Lactobacillus vaginalis GUH 0780928
22. Porphyromonas gingivalis ATCC 33277 24. Mobiluncus curtisii GUH 070927
23. Propionibacterium acnes (type I+II) ATCC11827/28 25. Mobiluncus mulieris GUH 070926
24. Selenomonas noxia ATCC 43541 26. Peptoniphilus sp. GUH 550970
25. Staphylococcus aureus ATCC 25923 27. Porphyromonas endodontalis ATCC35406
26. Streptococcus anginosus ATCC 33397 28. Peptostreptococcus anaerobius GUH 160362
27. Streptococcus constellatus ATCC 27823 (M32b) 29. Prevotella bivia GUH 450429
28. Streptococcus gordonii ATCC 10558 30. Prevotella disiens GUH 190184
29. Streptococcus intermedius ATCC 27335 31. Prevotella mirabilis GUH 070918
30. Streptococcus mitis ATCC 49456 32. Pseudomonas aeruginosa ATCC 33467
31. Streptococcus oralis ATCC 35037 33a. Staphylococcus aureus (yellow) GUH 070921
32. Streptococcus sanguinis ATCC 10556 33b. Staphylococcus aureus (white) GUH 070922
33. Streptococcus mutans ATCC 25175 34. Staphylococcus epidermidis GUH 130381
34. Tannerella forsythia ATCC 43037 (338) 35. Staphylococcus haemolyticus GUH071047
35. Treponema denticola ATCC 35405 36. Streptococcus agalactiae GUH 230282
36. Treponema socranskii D40DR2 37. Varibaculum cambriense GUH 070917
37. Veillonella parvula ATCC 10790
Legend: * ATCC: American Type Culture Collection; D: sample from Forsyth Institute, Massachusetts; GUH: Ghent University Hospital Collection, 
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ple comparisons was made and a statistically significant
difference was defined by p < 0.001. P-values < 0.01 and
< 0.05 were considered as trends of difference. Mantel-
Haenszel common odds ratios, sensitivity, and specificity
estimations were calculated in order to assess the predic-
tive utility of each vaginal bacterial species in diagnosing
gingivitis. The SPSS statistical software 16.0 for MAC OS X
was used for the analysis (SPSS Inc., Chicago, IL).
Results
A Nugent score of 0–3, considered as indicative for nor-
mal vaginal microflora without signs of inflammation,
was found in 83 women (46.1%), and a score of > 7, i.e.
clear BV was present in 49 women (27.2%). A total of 38
women (21.1%) had both BV and gingivitis, 54 (30.0%)
showed no evidence of either BV or gingivitis, 17 (9.4%)
had BV but not gingivitis, and 71 (39.4%) had gingivitis
but not BV. Women with a diagnosis of BV had a higher
proportion of tooth surfaces with evidence of gingivitis (p
= 0.007).
The vaginal microflora of women in relation to a diagnosis 
of bacterial vaginosis, and independent of gingival 
conditions
The bacterial species assessed are identified in Table 1. The
presence of streptococci, staphylococci and enterococci
studied did not differ by BV status. In vaginal samples
from women with BV, but independent of gingival status
significantly higher bacterial loads (p < 0.001) were
observed for the following 38/74 species: A. actinomyce-
temcomitans (Y4,), A. israelii, A. naeslundi, A. neuii, A. odon-
tolyticus, A. christensenii, B. biavatii, B. longum, B.
ureolyticus, C. gingivalis, C. aurimucosum, C. ochraceae, C.
sputigena, C. gracilis, C. rectus, C. showae, E. coli, E. corro-
dens, F. nucl. naviforme, F. nucl. nucleatum, F. nucl. polymor-
phum, F. periodonticum, H. influenzae, M. curtisii, M.
mulieris, P. micra, P. gingivalis, P. bivia, P. disiens, P. inter-
media, P. melaninogenica, P. nigrescens, P. acnes, P. aerugi-
nosa, T. forsythia, S. noxia, T. socranskii and V. cambriense.
However , L. crispatus, L. gasseri, L. iners, and L. vaginalis
were found at higher counts at sites without BV (p <
0.001).
The relationship between the vaginal microflora and 
gingivitis
Significantly higher vaginal bacterial counts (p < 0.001)
were found for 49/74 species (23 from panel 1 and 26
from panel 2) in BV+ women with a concurrent diagnosis
of gingivitis as compared to women who neither had BV
nor gingivitis. At the p < 0.001 level this included in addi-
tion to those reported above the following species: A. vagi-
nae, B. brevis, C. nigricans, Dialister sp., E. saburreum, L.
buccalis, N. mucosa, Petoniphilus sp., P. nigrescens, P. anaer-
obius, and V. parvula.
Table 2 presents the prevalence rates of bacterial species
collected from vaginal samples at the > 1 × 104 detection
level demonstrating statistically significant differences by
gingival status but independent of BV diagnosis. For 2 of
the 74 species tested, P. bivia and P. disiens, higher bacte-
rial counts were observed in subjects with gingivitis
(Mann-Whitney U-test, p < 0.001). Trends of differences
at the p < 0.01 level were also observed for B. ureolyticus,
M. curtisii, M. mulieris, and P. aeruginosa, as well as at the
p < 0.05 for G. vaginalis, P. intermedia, P. nigrescens, and V.
cambriense. The sensitivity, specificity and odds ratio char-
acteristics of the predictive values for the 6 species with
statistically significant odds distinguishing gingival status
are presented in Table 3. The remaining 4 species identi-
fied in Table 2 failed to qualify. Thus, when P. bivia was
present in the vaginal samples, the odds ratio for gingivitis
was 3.9 (95% CI 1.5–5.7, p < 0.001). When P. disiens was
present in the vaginal samples, the odds ratio for a diag-
nosis of gingivitis was 3.6 (95%CI: 1.8–7.5, p < 0.001).
The corresponding odds ratio for a diagnosis of BV was
5.3 for P. bivia (95%CI: 2.6 to 10.4, p < 0.001) and 4.4 for
P. disiens (95% CI: 2.2 to 8.8, p < 0.001).
Differences in bacterial levels by differentiation between 
subjects with any of four BV and gingivitis diagnostic 
combinations
The distributions of P. bivia and P. disiens in vaginal sam-
ples for the four different populations according to com-
bination of vaginal and gingival microflora (BV+/G+, BV-
/G-, BV+/G- and BV-/G+) are presented in a boxplot dia-
gram (Figure 1). Analysis by Kruskal-Wallis ANOVA iden-
tified differences in bacterial levels at the p < 0.001 level
by the combined vaginal and periodontal diagnostic crite-
ria for 49/74 species identified in vaginal samples
between BV+/G+ and BV-/G- women and at the p < 0.001
level for the following species: A. actinomycetemcomitans
Table 2: Prevalence of vaginal bacterial species (cut off level: > 1 
× 104 cells) for which a significant difference was observed by 
gingivitis status
Species No gingivitis
(n = 64)
Gingivitis
(n = 116)
p-value
Prevotella bivia 21.4 43.8 < 0.001
Prevotella disiens 15.7 40.2 < 0.001
Bacteroides ureolyticus 7.1 17.0 < 0.01
Mobiluncus curtisii 15.7 34.8 < 0.01
Mobiluncus mulieris 7.9 24.1 < 0.01
Pseudomonas aeruginosa 10.0 20.5 < 0.01
Gardnerella vaginalis 60.0 67.2 < 0.05
Prevotella intermedia 60.0 69.2 < 0.05
Prevotella nigrescens 10.8 24.3 < 0.05
Varibaculum cambriense 21.4 33.0 < 0.05
Legend: Expressed as percentages.Page 4 of 8
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Table 3: The predictive value of the presence (cut off level: 1 × 104 cells) of P. bivia, P. disiens, M. curtisii, M. mulieris, B. ureolyticus, and V. 
cambriense in vaginal samples for the diagnosis of gingivitis (20% cutoff level)
Microorganism Sensitivity Specificity Odds ratio 95% CI P-value
Prevotella bivia 0.18 0.97 3.9 1.7 to 33.8 < 0.001
Prevotella disiens 0.57 0.83 3.6 1.8 to 7.1 < 0.001
Mobiluncus curtisii 0.37 0.83 3.8 1.4 to 5.8 < 0.01
Mobiluncus mulieris 0.26 0.93 4.6 1.8 to 12.6 < 0.01
Bacteroides ureolyticus 0.21 0.93 3.3 1.2 to 9.1 < 0.02
Varibaculum cambriense 0.38 0.77 2.0 1.0 to 4.1 < 0.05
Boxplot diagram demonstrating differences in vaginal load for P. bivia and P. disiens by combined diagnostic criteria (Bacterial vaginosis neg nd gingivitis neg (BV-/G-), Bacterial v ginosis pos and Gi givitis pos. (BV+/G+), Bacterial vaginosis pos. nd Gin-givitis neg. (BV+/G-), and B cterial vagi osis eg. a d Gingivitis pos. (BV-/G+)Fi ure 1
Boxplot diagram demonstrating differences in vaginal load for P. bivia and P. disiens by combined diagnostic 
criteria (Bacterial vaginosis neg and gingivitis neg (BV-/G-), Bacterial vaginosis pos. and Gingivitis pos. (BV+/
G+), Bacterial vaginosis pos. and Gingivitis neg. (BV+/G-), and Bacterial vaginosis neg. and Gingivitis pos. (BV-/
G+). (* = extreme outliers, ° = outlier values).
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israelii, A. naeslundii, A. neuii, A. christensenii, A. vaginae, A.
odontolyticus, B. ureolyticus, B. biavatii, B. breve, B. longum,
C. nigricans, C. aurimucosum, C. gingivalis, C. gracilis, C.
ochracea, C. rectus, C. showae, Dialister sp. E. coli, E. corro-
dens, E. saburreum, F. nucl. nucleatum, F. nucl. polymor-
phum, F. nucl. naviforme, F. periodonticum, H. influenzae, L.
buccalis, M. curtisii, M. mulieris, Peptoniphilus sp., N.
mucosa, P. aeruginosa, P. micra, P. anaerobius, P. mirabilis,
P. bivia, P. disiens, P. intermedia, P. melaninogenica, P.
nigrescens, P. gingivalis, P. acnes, S. noxia, T. forsythia, T.
socranskii, V. cambriense, and V. parvula.
Specifically, higher counts in vaginal samples were found
in women in the BV+/G+ group in comparison to the
BV+/G- group for P. bivia, P. disiens, M. curtisii, and M.
mulieris (all at the p < 0.01 level). Further analysis demon-
strated that the sum of bacterial load including all 74 spe-
cies studies was higher in the BV+/G+ group than in the
BV+/G- group (p < 0.05), but was also higher than in sep-
arate comparisons with the two other possible diagnostic
combinations (p < 0.01).
Discussion
The checkerboard DNA-DNA hybridization method has
been demonstrated to be useful in studies of changes in
vaginal microflora during pregnancy [25,26]. Checker-
board DNA-DNA hybridization is also commonly used in
studies on the oral microflora [i.e. [13,14,16-18,20]], and
has also been used to assess the microflora in synovial
fluid of subjects with rheumatoid arthritis [27]. Studies of
the bacterial colonization of the oral cavity have shown
that Actinomyces sp. [28], Fusobacterium spp. [29], Prevo-
tella sp. [30], Capnocytophaga sp. [31] and T. forsythia [32]
are associated with gingivitis.
In accordance with the study by Boggess et al. [25], who
also using DNA-DNA hybridization in the assessment of
vaginal species the present study identified that B. ureolyti-
cus and M. curtisii were commonly found in vaginal sam-
ples. We also indentified that, in women with BV and
gingivitis and in comparison with those with BV but not
gingivitis, the vaginal samples demonstrated significantly
higher counts of bacteria commonly associated with peri-
odontal disease including: A. actinomycetemcomitans (Y4),
Fusobacterium sp., P. micra, P. intermeda P. gingivalis, and
T. forsythia. The role of these bacteria as potential infec-
tious etiological factors in adverse pregnancy outcomes in
the context of oral/gingival infection needs to be further
explored as also indicated by others [8,15]. The fact that
some bacterial species were found at higher counts in the
vaginal samples of women with BV and gingivitis than
among those only with BV may be an important observa-
tion suggesting that having gingivitis has an impact on the
bacterial load in women with BV.
The prevalence of gingivitis in our study population
(62%) was higher than the gingivitis prevalence of 48%
reported in NHANES III (National Health and Nutrition
Examination Survey) [33]. This may be explained by the
ethnic distribution and inclusion of many women with
low socio-economic status [34]. Studies that have associ-
ated periodontal disease with a risk of preterm birth have
used a variety of periodontal diagnostic criteria against
which the risk of preterm birth has been considered. One
of the problems is that periodontitis usually does not
present with unequivocal clinical evidence of disease until
subjects are at about age 40. Gingivitis is common in
younger age groups. The inflammatory response in gingi-
vitis is primarily a cellular immune response [35]. Data
from one study suggest that treatment of gingivitis in preg-
nant women significantly reduced the risk of preterm
birth [36]. Due to the fact that only 17 of the women with
a high risk for a preterm birth complication in the present
study delivered preterm, a statistical analysis of the data
based on delivery status was not performed.
This is the first study to demonstrate a link between vagi-
nal bacteria and gingivitis. Others have suggested that the
hematogenous route allows the spread of opportunistic
pathogens from one location to another [35]. It is also
plausible that opportunistic bacteria take advantage of
host specific factors and colonize wherever growth condi-
tions are suitable. The oral and vaginal environments may
provide such similar colonization and growth conditions
in a susceptible host. Further studies are warranted to
explore the relationship between oral and vaginal micro-
flora and infections. Further studies are warranted to
explore the relationship between the oral and vaginal
infection patterns and how this may explain why perio-
dontal disease (including gingivitis) may be a potential
adjunct cause of adverse pregnancy outcomes [2-8,15,36].
In a recent periodontal intervention study of pregnant
women with periodontitis, the data failed to demonstrate
that periodontal intervention had an impact on preg-
nancy outcomes [37]. Treatment was also restricted to
mechanical subgingival debridement and may not have
affected bacterial presence in relation to persistent gingivi-
tis, or reduced gingivitis to levels < 20% used as criteria in
the present study. Although the survival rate of premature
neonates has improved greatly in developed countries, the
prevalence of preterm birth rates have not declined and
various intervention studies to control for BV and other
risk factors have not been successful [38]. Thus, signifi-
cantly reducing preterm births may require a broader
approach to care not limited to vaginal conditions but
also include oral infections such as gingivitis.Page 6 of 8
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• Women with a diagnosis of BV have a higher proportion
of tooth surfaces with evidence of gingivitis
• Women with BV and gingivitis and in comparison to
those without BV and gingivitis have higher vaginal bacte-
rial counts including bacteria commonly associated with
both BV periodontal disease than women with BV but
without a diagnosis of gingivitis
• P. bivia, and P. disiens, may be of importance in women
with both BV and gingivitis.
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